SYNH — Syneos Health Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge Cap
- $4.46bn
- $7.08bn
- $5.39bn
Syneos Health Inc reports results for the quarter ended in March - Earnings Summary
Brief: Syneos Health Reports First Quarter 2022 Results
Brief: Syneos Health Names Michelle Keefe As CEO
Syneos Health Inc expected to post earnings of 95 cents a share - Earnings Preview
Contract researchers fall after Jefferies flags demand concerns
Baird says CROs to benefit as biotech funding 'fog' lifts
CRO investor concerns over dicey biotech funding environment overdone - Mizuho
Biotech related concerns are overblown, says Baird after decline in CRO stocks
Syneos Health Inc reports results for the quarter ended in December - Earnings Summary
Brief: Syneos Health Reports Fourth Quarter And Full Year 2021 Results
Charles River Lab slumps as weak biotech funding overshadows results beat
Syneos Health Inc expected to post earnings of $1.43 a share - Earnings Preview
JPMorgan Inv. Trusts - Ten Largest Investments
Decentralized clinical trials still a hot theme in 2022 - Baird
Brief: Syneos Health Appoints Two New Independent Directors
JPMorgan Inv. Trusts - Ten Largest Investments
Health insurers poised for strong 2022, hospitals to feel pressure- Mizuho
Baird sees growth for contract drug researchers after beat-and-raise year
JPMorgan Inv. Trusts - Ten Largest Investments